P2Y6R knockout mice are also protected against diet-induced obesity, having improved glucose tolerance and insulin sensitivity with reduced systemic inflammation, suggesting that P2Y6R antagonists might be used for treatment of obesity and type 2 diabetes [52, 103]. Here, INS is linked to obesity disorder.